Tracey L. McCain - Jun 29, 2021 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact for Tracey L. McCain
Stock symbol
KNSA
Transactions as of
Jun 29, 2021
Transactions value $
$0
Form type
4
Date filed
6/30/2021, 04:22 PM
Next filing
Sep 27, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +33.2K $0.00 33.2K Jun 29, 2021 Class A Common Shares 33.2K $14.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021.